Your browser doesn't support javascript.
loading
Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer.
Hamilton, Betty Ky; Rybicki, Lisa; Abounader, Donna; Andresen, Steven; Kalaycio, Matt; Sobecks, Ronald; Pohlman, Brad; Hanna, Rabi; Dean, Robert; Liu, Hien; Hill, Brian; Bolwell, Brian; Copelan, Edward.
Afiliação
  • Hamilton BK; Bone Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA. Electronic address: hamiltb2@ccf.org.
  • Rybicki L; Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA.
  • Abounader D; Bone Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Andresen S; Bone Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Kalaycio M; Bone Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Sobecks R; Bone Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Pohlman B; Bone Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Hanna R; Pediatric Hematology Oncology, Cleveland Clinic, Cleveland, OH, USA.
  • Dean R; Bone Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Liu H; Bone Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Hill B; Bone Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Bolwell B; Bone Marrow Transplant Program, Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Copelan E; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.
Hematol Oncol Stem Cell Ther ; 8(3): 115-24, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26183670
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Transplante de Células-Tronco Hematopoéticas / Neoplasias da Mama Masculina / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Transplante de Células-Tronco Hematopoéticas / Neoplasias da Mama Masculina / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article